ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.750,92
-0,31%
S&P 500
5.308,13
0,09%
US Dollar vs BRL
5,1046
0,00%
Bitcoin
71.289,83
-0,22%
Brent Oil
83,495
-0,04%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Angion Biomedica Corporation (ANGN)

  7. Angion Biomedica Corporation (ANGN) Notícias

ANGN

Angion Biomedica (ANGN)

Angion Biomedica Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ANGN
DataHoraFonteTítuloCódigoCompanhia
29/04/202408:00Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
05/04/202417:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
29/03/202416:28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANGNAngion Biomedica Corporation
29/03/202416:26Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ANGNAngion Biomedica Corporation
29/03/202414:58Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANGNAngion Biomedica Corporation
20/03/202417:37Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
20/03/202417:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
05/01/202418:05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ANGNAngion Biomedica Corporation
13/11/202310:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANGNAngion Biomedica Corporation
11/08/202322:13Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
07/07/202310:17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
14/06/202317:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ANGNAngion Biomedica Corporation
14/06/202315:43Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ANGNAngion Biomedica Corporation
12/06/202318:13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ANGNAngion Biomedica Corporation
05/06/202318:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANGNAngion Biomedica Corporation
05/06/202309:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANGNAngion Biomedica Corporation
01/06/202309:00GlobeNewswire Inc.Angion Biomedia Corp. Announces 1-for-10 Reverse Stock SplitNASDAQ:ANGNAngion Biomedica Corporation
24/05/202307:01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ANGNAngion Biomedica Corporation
10/05/202317:14Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ANGNAngion Biomedica Corporation
28/04/202317:46Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ANGNAngion Biomedica Corporation
28/04/202317:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ANGNAngion Biomedica Corporation
17/03/202317:26Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ANGNAngion Biomedica Corporation
14/02/202318:41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ANGNAngion Biomedica Corporation
17/01/202307:00GlobeNewswire Inc.Elicio Therapeutics and Angion Enter into Definitive Merger AgreementNASDAQ:ANGNAngion Biomedica Corporation
21/12/202223:50GlobeNewswire Inc.Angion Receives Nasdaq Notice Regarding Minimum Bid Price RequirementsNASDAQ:ANGNAngion Biomedica Corporation
15/08/202217:05GlobeNewswire Inc.Angion Provides Corporate Update and Reports Second Quarter 2022 Financial ResultsNASDAQ:ANGNAngion Biomedica Corporation
26/07/202207:17TipRanksH.C. Wainwright Reiterates Their Hold Rating on Angion Biomedica (ANGN)NASDAQ:ANGNAngion Biomedica Corporation
25/07/202217:30GlobeNewswire Inc.Angion Announces Process to Explore Strategic Alternatives for Enhancing and Preserving Shareholder ValueNASDAQ:ANGNAngion Biomedica Corporation
29/06/202217:05GlobeNewswire Inc.Angion Announces Discontinuation of Phase 2 Trial of ANG-3070 in Patients with Primary Proteinuric Kidney DiseaseNASDAQ:ANGNAngion Biomedica Corporation
27/05/202217:43Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:ANGNAngion Biomedica Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:ANGN

Seu Histórico Recente

LSE
73EC
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados